A system biology approach based on metabolic biomarkers and protein–protein interactions for identifying pathways underlying schizophrenia and bipolar disorder

• Published in: Scientific reports Vol. 11; no. 1; pp. 14450 - 11
• Main Authors: Altaf-Ul-Amin, Md, Hirose, Kazuhisa, Nani, João V., Porta, Lucas C., Tasic, Ljubica, Hossain, Shaikh Farhad, Huang, Ming, Ono, Naoaki, Hayashi, Mirian A. F., Kanaya, Shigehiko
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 14.07.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/114; 631/337; 631/378; 631/553; 692/53; 692/699; Biomarkers; Biomarkers - metabolism; Bipolar disorder; Bipolar Disorder - diagnosis; Bipolar Disorder - metabolism; Diagnosis; Etiology; Humanities and Social Sciences; Humans; Mental disorders; Metabolites; multidisciplinary; Protein interaction; Protein Interaction Maps; Proteins; Schizophrenia; Schizophrenia - diagnosis; Schizophrenia - metabolism; Science; Science (multidisciplinary); Statistical analysis; Systems Biology - methods
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-93653-3

Mental disorders (MDs), including schizophrenia (SCZ) and bipolar disorder (BD), have attracted special attention from scientists due to their high prevalence and significantly debilitating clinical features. The diagnosis of MDs is still essentially based on clinical interviews, and intensive efforts to introduce biochemical based diagnostic methods have faced several difficulties for implementation in clinics, due to the complexity and still limited knowledge in MDs. In this context, aiming for improving the knowledge in etiology and pathophysiology, many authors have reported several alterations in metabolites in MDs and other brain diseases. After potentially fishing all metabolite biomarkers reported up to now for SCZ and BD, we investigated here the proteins related to these metabolites in order to construct a protein–protein interaction (PPI) network associated with these diseases. We determined the statistically significant clusters in this PPI network and, based on these clusters, we identified 28 significant pathways for SCZ and BDs that essentially compose three groups representing three major systems, namely stress response, energy and neuron systems. By characterizing new pathways with potential to innovate the diagnosis and treatment of psychiatric diseases, the present data may also contribute to the proposal of new intervention for the treatment of still unmet aspects in MDs.